A comparative study of the role of disease severity in drug reimbursement decision making in four European countries. Issue 2 (February 2015)

• Record Type: Journal Article
• Authors: Franken, Margreet; Stolk, Elly; Scharringhausen, Tessa; de Boer, Anthonius; Koopmanschap, Marc
• Is Part Of: Health policy. Volume 119:Issue 2(2015)
• Page Start: 195
• Page End: 202
• Publication Date: 2015-02
• Subjects: Medical education -- Periodicals; Medical policy -- Periodicals; Delivery of Health Care -- Periodicals; Education, Medical -- Periodicals; Health Education -- Periodicals; Health Planning -- Periodicals; Public Policy -- Periodicals; Enseignement médical -- Périodiques; Politique sanitaire -- Périodiques; Medical education; Medical policy; Periodicals; Electronic journals; Electronic journals; 362.1
• DOI: 10.1016/j.healthpol.2014.10.007
• Languages: English
• ISSNs: 0168-8510

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0045"> <list id="lis0010"> <list-item id="lsti0005"> <label></label> <p id="par0005">In Belgium, France, The Netherlands and Sweden disease severity is an important, mostly implicit, consideration in drug reimbursement decision making.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Belgium and France explicitly use the level of severity of the disease to determine societal willingness to pay.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Most policymakers prefer qualitative information on the severity of the disease.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">Most policymakers prefer implicitly weighing all reimbursement decision criteria.</p> </list-item> </list> </p> </sec> </abstract>